Predicting Response to Immunotherapy: Assessing the Tumor Micro-Environment to Achieve Better Predictive Value than PD-L1 and TMB

ONCOCYTE
America/Los_Angeles (PT) -7

Description

PREDICTING RESPONSE TO IMMUNOTHERAPY: ASSESSING THE TUMOR MICRO-ENVIRONMENT TO ACHIEVE BETTER PREDICTIVE VALUE THAN PD-L1 AND TMB
Up to 750,000 patients are eligible for immunotherapy each year, yet more than half of these patients won’t respond. There continues to be a critical unmet need for a predictive biomarker than can identify responders and non-responders at diagnosis. DetermaIO is a novel test that measures expression of 27 genes from the tumor microenvironment and uses a proprietary algorithm to predict response to immunotherapies. In this webinar, we will present results from two studies showing the association of DetermaIO with response to checkpoint inhibitor therapy in non-small cell lung cancer (NSCLC) and triple negative breast cancer (TNBC). Both studies suggest that DetermaIO outperformed PD-L1 and/or TMB in predicting immunotherapy response. The studies were led by multiple leading academic institutions, including the University of Texas MD Anderson Cancer Center, Yale University, the Baylor College of Medicine, and the University of Tennessee Health Science Center.

Inglês

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES
 

Speakers

Naoto Ueno, Douglas Ross

 

Link to the Event

Banner to the Event

Predicting Response to Immunotherapy: Assessing the Tumor Micro-Environment to Achieve Better Predictive Value than PD-L1 and TMB
 
 
 

Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events

who%20goals_edited.png

DocMeeetings

Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us

Adress

Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A DocMeetings.com Company
Site Managed by:
QUALITY Soluções Web
1996-2020 "24 years inspiring technology"